samedan logo
 
 
 
spacer
home > pmps > winter 2003 > the ultimate solution for reducing medication errors
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Ultimate Solution for Reducing Medication Errors

Are the right patients receiving the right drugs in the right dosage at the right time? Preventing medication errors is high on the agenda not only of hospitals, but the pharmaceutical wholesalers, the pharmaceutical industry and also governments worldwide. The American health care sector is focusing on minimising errors in administering medication. By scanning medication at the patient's bedside, errors can be reduced by as much as 50 per cent or more according to the Federal Drug Administration (FDA). It is no wonder therefore that in mid-2003, the FDA ruled that there should be bar codes on each unit dose. Much research is carried out in order to calculate the percentage of medication errors occurring. Just about every country worldwide has done at least one research project on this subject.

Depending on which research report you read (and depending on the definition of medication error used) the percentage of medication errors varies between 10 and 25 per cent. Almost 0.5 per cent result in permanent injury and 0.25 per cent of patients die due to the wrong medicine or wrong dosage being administered. Although it looks like a small percentage in relation to the size of the population, this number is unacceptable. In addition, the costs of recovery, such as the expense of contra-medication and an extra stay in hospital, are estimated to be an annual ˆ300 million in countries such as The Netherlands. These figures are worrying, especially if you have ever been a patient, and solutions must be found.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Eric Tjoa, CEO at Tjoapack BV

Eric Tjoa founded TjoaPack, a pharmaceutical contract packaging company, in 1989. He holds a Masters in Pharmacy and has given several national and international presentations concerning bar coding and standardisation of unit dose packages, amongst other subjects, at the University of the Western Cape, the EAN conferences in 2002 and 2003, and at the EAHP 1999 in Nice.

spacer
Eric Tjoa
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

SGD Pharma introduces Ensiemo, the new complete child-resistant packaging solution for CBD oils

SGD Pharma today announces the launch of its new full packaging solution dedicated to the cannabidiol (CBD) oil market. Combining the company’s extensive pharmaceutical packaging expertise with the need for compliant, safe packaging for CBD oils, SGD Pharma has developed Ensiemo – a glass dropper and bottle offering that meets international regulatory standards.
More info >>

White Papers

The Promise and Challenge of Adaptive Design in Oncology Trials

Medpace

Clinical oncology trials are more complex and time consuming than those in any other therapeutic area and failure rates are frustratingly high. Given the urgent need for new oncologic therapies, sponsors are eager to find more effective ways to conduct clinical research. Incorporating adaptive design methodologies into clinical trials can reduce costs and enhance efficiency while maintaining trial integrity. They can also reduce the number of patients on placebo and sub-therapeutic doses. In light of this promise, regulatory bodies have created guidelines supportive of adaptive design.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement